Metoject 17.5 mg/0.35ml (Methotrexate PFS) 17.5 mg/0.35ml

Metoject 17.5 mg/0.35ml is a pre-filled syringe containing methotrexate, a medication used for certain inflammatory conditions. It belongs to the class of disease-modifying antirheumatic drugs (DMARDs). Store in a cool, dry place away from light.

Strength

17.5 mg/0.35ml

Manufacturer / TM Owner

Gebro pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methotrexate, the active ingredient in Metoject 17.5 mg/0.35ml, is commonly prescribed to manage symptoms of rheumatoid arthritis, psoriasis, and other autoimmune disorders. It helps reduce inflammation and slow disease progression. Patients often ask, 'what is methotrexate used for' in managing chronic conditions.

Side Effects

Metoject 17.5 mg/0.35ml may help alleviate joint pain, swelling, and stiffness associated with inflammatory conditions. Some users report improved mobility and reduced flare-ups over time. Individual responses vary, and effects may take several weeks to become noticeable.

Precautions & Warnings

Metoject 17.5 mg/0.35ml should be handled with care, as methotrexate is a potent medication. Avoid contact with skin or mucous membranes; use gloves when handling. Keep out of reach of children and pets. Regular blood tests may be required to monitor safety.

Avoid Interactions

Methotrexate can interact with other medications, including certain antibiotics, NSAIDs, and folic acid supplements. Alcohol may increase the risk of side effects, so it’s best to avoid it. Always inform your healthcare provider about all medications you are taking before starting Metoject.

Frequently Asked Questions

Methotrexate is primarily used to treat rheumatoid arthritis, psoriasis, and other autoimmune conditions by reducing inflammation.

Metoject is a pre-filled syringe designed for subcutaneous injection; follow your doctor’s instructions for proper use.

Methotrexate is a prescription medication and should only be obtained with a valid prescription from a licensed healthcare provider.

Common side effects may include nausea, fatigue, or mild hair thinning; consult your doctor if symptoms persist.

Methotrexate is not recommended during pregnancy due to potential risks; discuss family planning with your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.